Coya: COYA 301 – GLP-1 agonists combo synergistic in inflamation amelioration
Coya Therapeutics (COYA) releases the following letter to stockholders from Chief Executive Officer Dr. Arun Swaminathan….”Given my recent ...
health.economictimes.indiatimes1h
4 Best Natural Ozempic Alternatives Over the Counter for Effective and Safe Weight Loss
Looking for natural alternatives to Ozempic that offer effective and safe weight loss? Many people choose Ozempic for ...
More than half of U.S. adults might be candidates for Ozempic
More than half of all American adults, almost 137 million people, could be candidates for the blockbuster GLP-1 drug ...
This new supplement aims to support natural GLP-1 production and gut health
Inno Supps’ Trim Biome™ GLP-1 is designed to support the body’s natural production of GLP-1 through a unique blend of ...
News Medical6h
Anti-obesity drugs show promise in improving cardiovascular health beyond weight loss
Popular anti-obesity drugs continue to show cardiovascular benefits beyond weight loss, according to several new papers published in JACC, the flagship journal of the American College of Cardiology, ...
News Medical7h
Impact of glucagon-like peptide-1 receptor agonists on alcohol consumption: A systematic review
The impact of GLP-1 RAs on alcohol use is explored, showing potential benefits in reducing intake and cravings, but with ...
Hosted on MSN15h
'Staggeringly high' discontinuation rates for GLP-1 drugs like Ozempic or Wegovy
The use of diabetes and weight-loss medications like Ozempic or Wegovy—called GLP-1 drugs—has exploded in recent ... Khan et al, Discontinuation of Glucagon-Like Peptide-1 Receptor Agonists, JAMA ...
Amgen Sells Off: Keep Calm And Buy The Dip
Analyzing Amgen's stock drop, management's response, and potential for growth in GLP-1 candidate MariTide in a volatile ...